68 results
Page 2 of 4
S-3
EX-10.3
mtdttv36pauzcy23
15 Apr 21
Shelf registration
4:03pm
8-K/A
uo78akdq
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
8-K
EX-3.1
jyaid5j
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
424B3
jur0y mxzf25lfbl4e
12 Feb 21
Prospectus supplement
12:05pm
S-4/A
sb1jxb59ldsh9gmj9pv3
10 Feb 21
Registration of securities issued in business combination transactions (amended)
1:19pm
S-4
pn23n3au
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-2.1
7o0ptgwjb8apxy9sn
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.2
sqv0uu0ciazvo e3
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.4
1as4dgm868i ife07g
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-3.1
8u4113q
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.3
9mb3pd
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.5
v96bjb
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-2.7
butnva
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.6
bfzqyap sky59
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
EX-2.1
c0dtl9unjyqwxshy17aw
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-2.1
71cbs5is9z nlf92328b
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEF 14A
asgr4u74hglu60q
6 Apr 20
Definitive proxy
6:11am
PRE 14A
bb1xwna
30 Mar 20
Preliminary proxy
5:03pm
10-K
994xa36c9rf8w
17 Mar 20
Annual report
5:27pm